hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas
- PMID: 10945633
hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas
Abstract
DNA mismatch repair genes have been implicated in the pathogenesis and predisposition of certain malignancies through a mutator phenotype. In this study, we investigated, in 150 non-small cell lung carcinomas, the expression levels of hMLH1 and hMSH2 proteins in relation to loss of heterozygosity on chromosomes 3p and 2p, the mutational status of these genes' promoters and the hot spot exons. We have demonstrated that 88 of 150 (58.6%) tumor specimens had reduced expression levels of the hMLH1 protein, whereas 85 of 147 (57.8%) specimens had reduced expression levels of the hMSH2 protein. Reduced expression levels of both proteins were observed in 51 of 150 (34%) specimens. In adenocarcinomas, the reduction of hMSH2 expression was more frequently observed than that of hMLH1 (P<0.003), whereas in squamous cell carcinoma of the lung hMLH1 expression was more frequently reduced than hMSH2 (P<0.006). Reduced expression of hMLH1correlated with allelic imbalance on loci D3S1289 (P<0.0002) and D2S391 (P<0.05). It is of note that an inverse correlation was found between hMSH2 reduced expression and loss of heterozygosity at locus D3S1300 (P = 0.016). In addition, hMLH1 reduced expression was more frequently associated with heavy smokers, assessed by daily tobacco uptake (P = 0.018) and total smoking exposure (pack-years; P<0.05). In addition, a correlation between hMLH1 reduced expression and nodal metastasis in squamous cell carcinoma of the lung was observed (P = 0.015). No mutations were identified in the promoters or exons examined in these two genes. These findings indicate that hMLH1 and hMSH2 gene inactivation is a common event in the development of non-small cell lung carcinoma and allelic loss seems to be a major genetic event involved in hMLH1 silencing. In addition, we propose that a putative negative regulator of hMSH2 gene may be located at the locus 3p14.
Similar articles
-
Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples.J Clin Invest. 2003 Mar;111(6):887-95. doi: 10.1172/JCI15475. J Clin Invest. 2003. PMID: 12639995 Free PMC article.
-
Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.Cancer Res. 1999 Aug 1;59(15):3570-5. Cancer Res. 1999. PMID: 10446963
-
Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.Hum Pathol. 2003 Sep;34(9):841-9. doi: 10.1016/s0046-8177(03)00343-5. Hum Pathol. 2003. PMID: 14562278
-
Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.Oral Oncol. 2003 Feb;39(2):115-29. doi: 10.1016/s1368-8375(02)00028-3. Oral Oncol. 2003. PMID: 12509964
-
Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.Adv Cancer Res. 1997;71:27-92. doi: 10.1016/s0065-230x(08)60096-2. Adv Cancer Res. 1997. PMID: 9111863 Review.
Cited by
-
Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis.Med Oncol. 2013 Jun;30(2):532. doi: 10.1007/s12032-013-0532-9. Epub 2013 Mar 17. Med Oncol. 2013. PMID: 23504373 Free PMC article.
-
Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: prognostic implications.Br J Cancer. 2004 May 17;90(10):1983-8. doi: 10.1038/sj.bjc.6601775. Br J Cancer. 2004. PMID: 15138482 Free PMC article.
-
DNA methylation: its role in cancer development and therapy.Curr Probl Cancer. 2008 Sep-Oct;32(5):187-235. doi: 10.1016/j.currproblcancer.2008.08.002. Curr Probl Cancer. 2008. PMID: 18926282 Free PMC article. Review. No abstract available.
-
Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions.Histopathology. 2008 Apr;52(5):613-22. doi: 10.1111/j.1365-2559.2008.02999.x. Histopathology. 2008. PMID: 18370958 Free PMC article.
-
Small suitability of the DLEC1, MLH1 and TUSC4 mRNA expression analysis as potential prognostic or differentiating markers for NSCLC patients in the Polish population.J Genet. 2017 Jun;96(2):227-234. doi: 10.1007/s12041-017-0770-2. J Genet. 2017. PMID: 28674222
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical